Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
N/A
Regarding nitrogen metabolism, P. ruminicola 23 can efficiently utilize both ammonia and peptides (preferentially larger peptides, up to 2,000_Da) as a nitrogen source for growth. For breakdown of oligopeptides, P. ruminicola 23 harbors the greatest range and specific activity of dipeptidyl peptidases in comparison to species belonging to other abundant genera in the rumen, such as Butyrivibrio, Ruminococcus, and Fibrobacter. [PMID: 28798330] The strain possesses the capacity to degrade plant cell wall polysaccharides, proteins, and peptides, contributing to the utilization of noncellulosic polysaccharides, such as starch and xylan (adapted from PMID 19304844). [UP000000927]
Prevotella ruminicola 23 is an obligate anaerobic bacterium that contributes to hemicellulose utilization within the bovine rumen. It is one of the most commonly isolated species from rumen contents and possesses the capacity to degrade plant cell wall polysaccharides, proteins, and peptides, contributing to the utilization of noncellulosic polysaccharides, such as starch and xylan (adapted from PMID 19304844). [UP000000927]
Holdeman, L. V., Good, I. J., & Moore, W. E. (1976). Human fecal flora: variation in bacterial composition within individuals and a possible effect of emotional stress. Applied and Environmental Microbiology, 31(3), 359–375.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces, rumen, and chicken gut
DNA G+C(%): 45-52
|
Lower T(℃): 30(+)
Mid T(℃): 37(+)
High T(℃): 45(neg)
Bile reaction(%): 20(neg)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
|
cefoperazone: Var(MIC50): 4, MIC90: 64, RNG: (0.5-128)
cefotaxime: Var(MIC50): 1, MIC90: 32, RNG: (≤0.062-64)
cefoxitin: Var(MIC50): 2, MIC90: 8, RNG: (1-16)
ceftazidime: Var(MIC50): 4, MIC90: 256, RNG: (2->256)
moxalactam: Var(MIC50): 1, MIC90: 16, RNG: (0.5-128)
|
|
|
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
|
|
|
metronidazole: S(MIC50): 0.5, MIC90: 2, RNG: (0.25-2)
|
clindamycin: S(MIC50): ≤0.062, MIC90: 2, RNG: (<0.062-4)
|